Diabetes

April 29, 2017

Texas Onglyza Heart Failure Lawsuit

Onglyza Heart Failure. Wrendell Chester, from Texas, recently filed a personal injury and product liability lawsuit, against Bristol-Myers Squibb and AstraZeneca, the manufacturers of the drug.

Chester claims that the companies failed to adequately warn patients and doctors about the risk of heart failure from side effects of Onglyza and failed to conduct proper research and testing.

According to Chester’s lawsuit in the U.S. District Court for the Southern District of Texas, he suffered serious heart failure injuries after using Onglyza and Kombiglyze XR.

October 14, 2015

Texas Actos Attorney Provides Bladder Cancer Settlement Update

by Dr. Shezad Malik

Takeda Pharmaceuticals has decided to wrap up the remaining Actos linked bladder cancer lawsuits. Takeda settled two more claims this week, after a two-month trial in Nevada state court.

Recently, Takeda ear-marked $2.4 billion for settlements to settle thousands of personal injury and defective product liability lawsuits brought by diabetic patients who were diagnosed with bladder cancer after using Actos.

Actos Settlement Band Wagon Keeps On Rolling

In September, Takeda said that 96% of Actos claimants signed up for its $2.3 billion settlement offer, settling most of the 8,000 plus cases pending in state and federal courts.

On other fronts, Takeda settled the 7 out of 9 cases that had been tried and were up on appeal. Takeda also agreed to toss in an extra $100 million if 97% of claims matched up with settlement criteria. Takeda is trying close down the Actos bladder litigation, by encouraging as many plaintiffs as possible to settle their injury claims and keep the settlement band wagon rolling on.

July 11, 2015

Invokana Diabetes Drug Side Effects Lawsuits

by Dr. Shezad Malik

According to the FDA recent warning, there are serious issues and side effects with the new class of medications used to treat type 2 diabetes.

What is Invokana?

Johnson & Johnson’s Janssen Pharmaceuticals unit manufactures and distributes Invokana (canagliflozin), for patients with type-2 diabetes, to control their blood-sugar levels. The drug has achieved blockbuster status, in that it is set to blow past a billion dollars in sales in 2015.

August 12, 2014

Actos Bladder Cancer Questions and Answers

by Dr. Shezad Malik

There are several thousand lawsuits filed by folks both in state and federal courts by patients who took the prescription drug pioglitazone, sold as brand name Actos and later developed bladder cancer. Doctors prescribe Actos to treat patients with Type 2 Diabetes.

Takeda Actos Bladder Cancer Verdict

On April 7, 2014, a federal jury in Louisiana found Takeda failed to adequately warn about bladder cancer risks of Actos. Jurors also found that executives of Takeda acted with wanton and reckless disregard for patient safety and awarded a total of $9 billion in punitive damages.

August 4, 2014

Takeda Seeks New Trial After Losing Actos Bladder Cancer Trial

by Dr. Shezad Malik

After a record breaking pharmaceutical $9 billion jury verdict involving Actos bladder cancer lawsuit, Takeda Pharmaceuticals and Eli Lilly, Actos manufacturers, have filed for a new trial. Takeda Pharmaceuticals and Eli Lilly, claim that the massive award shows that the jury acted with “passion and prejudice”.

Actos Record $9B Verdict

In April, a federal jury in Louisiana hammered Takeda with $1.5 million in compensatory damages and a whopping $9 billion in punitive damages. Terrance Allen and his wife’s claim, was the first out of several thousand Actos lawsuits in the federal court system to go to trial.

April 9, 2014

Louisiana Jury Hammers Takeda Actos Bladder Cancer $9 Billion Verdict

by Dr. Shezad Malik

The jury in federal court in Louisiana, sent a loud and clear message on Monday, in rendering a bombshell verdict. Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages. The federal court jury found they hid the cancer risks of their Actos diabetes drug in the first federal U.S. trial.

https://www.youtube.com/watch?v=G4ItYan1QWo&feature=player_detailpage

Takeda, Lilly $9 Billion Punitive DamagesTakeda, based in Osaka, Japan, was ordered to pay $6 billion by the jury yesterday in Lafayette, Louisiana. Indianapolis-based Eli Lilly, Takeda’s partner, was ordered to pay $3 billion. Punitive damages are awarded in these types of cases to punish the companies for their wrongful acts.

April 6, 2014

Louisiana Actos Bladder Cancer Trial Verdict Pending

by Dr. Shezad Malik

After 33 grueling days of hotly contested trial testimony, the first federal Actos bladder cancer lawsuit trial has ended. The jury is scheduled to hear closing arguments on Monday and then deliberations will begin.

Federal Actos Trial: The Details

January 22, 2014

Actos Bladder Cancer Set for Federal Trial

by Dr. Shezad Malik

January 5, 2014

California Byetta, Januvia Pancreatic Cancer Lawsuits

by Dr. Shezad Malik

All Byetta, Januvia, Janumet and Victoza cancer lawsuits are consolidated and centralized as part of an MDL, or Multidistrict Litigation.

These product liability cases involve pancreatic cancer after the use of Byetta, Januvia, Janumet or Victoza as part of the “Incretin Mimetics Product Liability Litigation.”

September 25, 2013

Actos Trial: Takeda Duped Patients, Doctors on Actos Bladder Cancer Risk

by Dr. Shezad Malik

According to the testimony presented in trial, Takeda Pharmaceutical Co. duped patients and doctors about the risks of its Actos diabetes drug and should be held liable for the cancer death of a former U.S. Army translator.

Takeda did not disclose Bladder Cancer Risks

The plaintiff alleged that Japan-based Takeda, failed to provide any warning until 2011 that researchers had linked Actos to bladder cancer. The family of Diep An, filed a wrongful death product liability lawsuit in state court in Baltimore, MD. The plaintiff’s attorney allege that the lack of a warning allowed the company to protect billions in sales of the drug.